Survival in polymyositis: corticosteroids and risk factors.

J. R. Carpenter, T. W. Bunch, A. G. Engel, P. C. O'Brien

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


Thirty-one polymyositis patients treated with low-dose corticosteroid were age and sex matched with 31 polymyositis patients treated with high-dose corticosteroid. Although disease severity at onset of the study was similar in the groups, no statistically significant difference in survival was found. The death rate in each group was greater than normal. The presence of dysphagia or severe muscle weakness lessened the chances of survival. Controlled trials with other drugs should be carried out.

Original languageEnglish (US)
Pages (from-to)207-214
Number of pages8
JournalJournal of Rheumatology
Issue number2
StatePublished - Jun 1977

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology


Dive into the research topics of 'Survival in polymyositis: corticosteroids and risk factors.'. Together they form a unique fingerprint.

Cite this